Skip to main content
. 2021 Aug 15;13(8):856–866. doi: 10.4251/wjgo.v13.i8.856

Table 1.

Recommendations for colorectal cancer screening across professional organizations[54]

Professional organization
Recommended ages for screening
Recommended screening tests
Other considerations
U.S. Preventive Services Task Force (2016) 50-75 gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy
U.S Multi-Society Task Force on Colorectal Cancer (2017) 50-75 FIT, colonoscopy (Tier 1)1 Screening at age 45 yr for African Americans; AGA endorses Canadian guidelines on screening in setting of family history
National Comprehensive Cancer Network (2018) 50-75 gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy Focused guidelines address screening for high-risk syndromes
American College of Physicians (2012) 50-75 gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy, DCBE
Canadian Task Force on Preventive Health Care (2016) 50-74 gFOBT, FIT, sigmoidoscopy Weak recommendation for screening in ages 50-59 yr
American Cancer Society (2018) 45-75 gFOBT, FIT, FIT-DNA, colonoscopy, CT colonography, sigmoidoscopy Qualified recommendation for initiating screening at age 45 yr — uncertainty regarding ratio of benefits to harms

Modified from Murphy[54].

1

Tier 2 tests include computed tomography colonography, fecal immunochemical tests-DNA, flexible sigmoidoscopy.

gFOBT: Guaiac-based fecal occult blood tests; FIT: Fecal immunochemical tests; CT: Computed tomography; AGA: American Gastroenterological Association.